Details of the Drug

General Information of Drug (ID: DMXMTLP)

Drug Name	6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analog 3
Synonyms	PMID28067079-Compound-111
Drug Type	Small molecular drug
Structure
Structure	3D MOL	2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)	339.4
	Logarithm of the Partition Coefficient (xlogp)	1.3
	Rotatable Bond Count (rotbonds)	3
	Hydrogen Bond Donor Count (hbonddonor)	1
	Hydrogen Bond Acceptor Count (hbondacc)	6
Chemical Identifiers	Formula C15H13N7OS IUPAC Name 6-(2-methylpyrazol-3-yl)-N-(4-methyl-1,3-thiazol-2-yl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamide Canonical SMILES CC1=CSC(=N1)NC(=O)C2=CC(=CN3C2=NC=N3)C4=CC=NN4C InChI InChI=1S/C15H13N7OS/c1-9-7-24-15(19-9)20-14(23)11-5-10(12-3-4-17-21(12)2)6-22-13(11)16-8-18-22/h3-8H,1-2H3,(H,19,20,23) InChIKey POJPLPZXVLFMAM-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 121263181 TTD ID D0T9IR

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Metabotropic glutamate receptor 5 (mGluR5)	TTHS256	GRM5_HUMAN	Modulator	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Metabotropic glutamate receptor 5 (mGluR5)	DTT	GRM5	9.81E-07	-0.26	-0.54

Molecular Expression Atlas (MEA)

Jump to Detail Molecular Expression Atlas of This Drug

References

1	mGlu5 negative allosteric modulators: a patent review (2013 - 2016).Expert Opin Ther Pat. 2017 Jun;27(6):691-706.